Avillion Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

Avillion General Information

Description

Provider of drug development financing and operational services intended to assist pharma and biotech organizations in their development and financing of later-stage pharmaceutical products. The company's services facilitate the acceleration of global drug development through successful partnering for patient benefit by providing strategic development and regulatory expertise, funding, global CRO management, and risk-sharing, enabling pharmaceutical and biotechnology companies to continue to develop their most important drug candidates without increasing the burden on their P&L or cash reserves and advance late-stage clinical development projects through to market approval.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Orega, 4 Longwalk
  • Stockley Park
  • Uxbridge UB11 1FE
  • England, United Kingdom
+44 020 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avillion Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Jul-2021 Completed Clinical Trials - Phase 3
2. Early Stage VC 06-May-2014 Completed Clinical Trials - Phase 3
1. Early Stage VC 28-Jan-2013 Completed Clinical Trials - Phase 3
To view Avillion’s complete valuation and funding history, request access »

Avillion Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of drug development financing and operational services intended to assist pharma and biotech organizations in t
Drug Discovery
Uxbridge, United Kingdom
40 As of 2022
00000000000

000 00

or incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis no
0000 000000000
Pleasanton, CA
00 As of 0000
0000
000000 - 000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avillion Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SFJ Pharmaceuticals Venture Capital-Backed Pleasanton, CA 00 0000 000000 - 000 0000
You’re viewing 1 of 1 competitors. Get the full list »

Avillion Executive Team (11)

Name Title Board Seat Contact Info
Allison Jeynes-Ellis MD Chief Executive Officer
Mark Weinberg MD Chief Medical Officer & President
Mary Sheahan Chief Financial Officer
Anna Danilewicz Vice President Clinical Development
Ulf Wiinberg Senior Advisor
You’re viewing 5 of 11 executive team members. Get the full list »

Avillion Board Members (6)

Name Representing Role Since
Anders Pedersen MD Self Board Member 000 0000
Genghis Lloyd-Harris Ph.D Abingworth Board Member 000 0000
Jim Reddoch Ph.D Royalty Pharma Board Member 000 0000
Kurt Wheeler Blackstone Life Sciences Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Avillion Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avillion Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Royalty Pharma PE/Buyout Minority 000 0000 000000 0
To view Avillion’s complete investors history, request access »

Avillion FAQs

  • When was Avillion founded?

    Avillion was founded in 2011.

  • Who is the CEO of Avillion?

    Allison Jeynes-Ellis MD is the CEO of Avillion.

  • Where is Avillion headquartered?

    Avillion is headquartered in Uxbridge, United Kingdom.

  • What is the size of Avillion?

    Avillion has 40 total employees.

  • What industry is Avillion in?

    Avillion’s primary industry is Drug Discovery.

  • Is Avillion a private or public company?

    Avillion is a Private company.

  • What is Avillion’s current revenue?

    The current revenue for Avillion is 00000.

  • Who are Avillion’s investors?

    Royalty Pharma has invested in Avillion.

  • Who are Avillion’s competitors?

    SFJ Pharmaceuticals is a competitor of Avillion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »